Breaking News

Biden administration spends $100M on open enrollment navigators

Not rendering correctly? View this email as a web page here.

Amgen's Phase 3 win in lung cancer puts pressure on Mirati bid for speedy FDA nod

By Frank Vinluan Tuesday, August 30, 2022 10:25 PM

Amgen said its drug Lumakras met the main goal of a Phase 3 study in non-small cell lung cancer driven by a particular genetic mutation. The pharmaceutical giant offered no specifics, but the results set the stage for an interesting regulatory race with a rival drug from Mirati Therapeutics

Read more »

Avenda Health scores $10M to personalize prostate cancer care

By Katie Adams Tuesday, August 30, 2022 5:58 PM

Avenda Health, an AI company focused on personalized prostate cancer care, recently closed a $10 million Series B funding round. The company's platform seeks to personalize treatment to the patient and their specific case to preserve quality of life and prevent cancer recurrence.

Read more »

Real-word health data firm launches with backing from WashU Medicine, BJC HealthCare

By Katie Adams Tuesday, August 30, 2022 4:51 PM

Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine. The company's mission is to leverage its two institutional partners' deep data resources to create more useful data that enables quicker discoveries of new diagnostics and medical interventions.

Read more »

Empire BCBS adds 4 virtual behavioral health companies to its provider network

By Marissa Plescia Tuesday, August 30, 2022 2:16 PM

The four companies are Alma, Headway, NOCD and Ophelia. Alma and Headway will help Empire expand its mental health provider network, while NOCD and Ophelia will address specific conditions: obsessive-compulsive disorder and opioid use disorder, respectively.

Read more »

The compounding effects of inflation on health and health outcomes

By Ryan Bosch Tuesday, August 30, 2022 2:00 PM

Decreased spending power compounds the impact of social risk particularly by surfacing other associated deficiencies in areas such as health literacy, digital access and social isolation.

Read more »

Brain-focused Neurocrine buys a biotech to broaden its scope in hormone disorders

By Frank Vinluan Tuesday, August 30, 2022 1:10 PM

Neurocrine Biosciences is acquiring Diurnal Group, a U.K-based biotech that has commercialized two endocrine disorder drugs. Neurocrine's top-selling product is a blockbuster drug for an involuntary muscle movement disorder.

Read more »

Putting patients at the center of RWD collection processes [Sponsored]

By Stephanie Baum Tuesday, August 30, 2022 12:33 PM

In a recent interview, Jennifer Cubino, COO of BC Platforms, discussed regulatory differences between the U.S., the European Union and other countries amid ongoing efforts to encourage patients who want to share their data.

Read more »

Reducing care disparities in orthopedics

By Bronwyn Spira Tuesday, August 30, 2022 8:30 AM

In the near future, healthcare organizations will likely need to document how they collect health equity data, screen patients for social determinants of health, and address disparities in care.

Read more »

   

No comments